Insiders VYNE Therapeutics Inc.

Equities

Delayed Nasdaq Other stock markets 10:17:59 2023-12-04 am EST			5-day change	1st Jan Change
3.415 ^USD	-1.59%		-13.98%	+26.48%

Nov. 13	Earnings Flash (VYNE) VYNE THERAPEUTICS Posts Q3 Revenue $114,000	MT
Nov. 13	VYNE Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

VYNE Therapeutics Inc. Names Tyler Zeronda as Treasurer	2022	CI
VYNE Therapeutics Inc. Announces Board Changes	2022	CI
Insider Trends: Selling By Insiders Lingers at VYNE Therapeutics	2021	MT
Insider Trends: Insider Sales Add to 90-Day Trend at VYNE Therapeutics	2021	MT
Insider Trends: Insider 90-Day Selling Trend Prolonged at VYNE Therapeutics	2021	MT
VYNE Therapeutics Inc. Announces Executive Changes, Effective June 18, 2021	2021	CI
Insider Trends: Insider Sales Add to 90-Day Trend at VYNE Therapeutics	2021	MT
Insider Trends: Insider Buying Added to with Purchase of VYNE Therapeutics Shares	2021	MT
VYNE Therapeutics Inc. Appoints Patrick G. Lepore to its Board of Directors	2020	CI
Menlo Therapeutics Inc. Announces Board Changes	2020	CI
Menlo Therapeutics Inc. Announces Executive Changes	2020	CI
Foamix Pharmaceuticals Ltd. Announces Board Resignations	2020	CI
Foamix Pharmaceuticals Ltd. Announces Board Appointments	2020	CI
Menlo Therapeutics Inc. Announces Management Changes	2020	CI
Menlo Therapeutics Inc. Announces Resignation of Aaron Royston from the Board and the Nominating and Corporate Governance Committee of the Board	2019	CI
Menlo Therapeutics Inc. Announces Management Appointment	2019	CI
Menlo Therapeutics Inc. Announces Executive Changes, Effective May 31, 2019	2019	CI
Menlo Therapeutics Inc. Announces Board Changes	2019	CI
Dalia Megiddo Resigns from Board of Foamix Pharmaceuticals Ltd	2019	CI
Foamix Pharmaceuticals Ltd Announces Appointment of Sharon Barbari to Board of Director	2019	CI

No results for this search